Chromatin immunoprecipitation combined with massively parallel sequencing methods (ChIP-seq) is becoming the standard approach to study interactions of transcription factors (TF) with genomic sequences. At the example of public STAT1 ChIP-seq data sets, we present novel approaches for the interpretation of ChIP-seq data.We compare recently developed approaches to determine STAT1 binding sites from ChIP-seq data. Assessing the content of the established consensus sequence for STAT1 binding sites, we find that the usage of "negative control" ChIP-seq data fails to provide substantial advantages. We derive a single refined probabilistic model of STAT1 binding sequences from these ChIP-seq data. Contrary to previous claims, we find no evidence ...
International audienceChromatin immunoprecipitation followed by se-quencing (ChIP-seq) is the most p...
International audienceDramatic progress in the development of next-generation sequencing technologie...
International audienceDramatic progress in the development of next-generation sequencing technologie...
ChIP-Seq is a technology for detecting in vivo transcription factor binding sites or histone modific...
ChIP-Seq is a technology for detecting in vivo transcription factor binding sites or histone modific...
Abstract Background Chromatin immunoprecipitation coupled with massively parallel sequencing (ChIP-s...
Binding of transcription factors on specific sites of DNA is central to the regulation of gene expre...
Background: Chromatin immunoprecipitation (ChIP) coupled to high-throughput...
Chromatin immunoprecipitation followed by sequencing (ChIP-seq) is the most popular assay to identif...
BACKGROUND: Signal transducer and activator of transcription (STAT) proteins are key regulators of g...
On benefit of the rapid growth of ultra-high-throughput sequencing technologies in recent years, ChI...
Background: The global effort to annotate the non-coding portion of the human genom...
International audienceChromatin immunoprecipitation followed by se-quencing (ChIP-seq) is the most p...
Coupling chromatin immunoprecipitation (ChIP) with recently developed massively parallel sequencing ...
International audienceChromatin immunoprecipitation followed by se-quencing (ChIP-seq) is the most p...
International audienceChromatin immunoprecipitation followed by se-quencing (ChIP-seq) is the most p...
International audienceDramatic progress in the development of next-generation sequencing technologie...
International audienceDramatic progress in the development of next-generation sequencing technologie...
ChIP-Seq is a technology for detecting in vivo transcription factor binding sites or histone modific...
ChIP-Seq is a technology for detecting in vivo transcription factor binding sites or histone modific...
Abstract Background Chromatin immunoprecipitation coupled with massively parallel sequencing (ChIP-s...
Binding of transcription factors on specific sites of DNA is central to the regulation of gene expre...
Background: Chromatin immunoprecipitation (ChIP) coupled to high-throughput...
Chromatin immunoprecipitation followed by sequencing (ChIP-seq) is the most popular assay to identif...
BACKGROUND: Signal transducer and activator of transcription (STAT) proteins are key regulators of g...
On benefit of the rapid growth of ultra-high-throughput sequencing technologies in recent years, ChI...
Background: The global effort to annotate the non-coding portion of the human genom...
International audienceChromatin immunoprecipitation followed by se-quencing (ChIP-seq) is the most p...
Coupling chromatin immunoprecipitation (ChIP) with recently developed massively parallel sequencing ...
International audienceChromatin immunoprecipitation followed by se-quencing (ChIP-seq) is the most p...
International audienceChromatin immunoprecipitation followed by se-quencing (ChIP-seq) is the most p...
International audienceDramatic progress in the development of next-generation sequencing technologie...
International audienceDramatic progress in the development of next-generation sequencing technologie...